{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T23:40:24Z","timestamp":1794699624546,"version":"4.9.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","funder":[{"name":"Agence Nationale de la Recherche","award":["ANR-22-PESN-0017"],"award-info":[{"award-number":["ANR-22-PESN-0017"]}],"id":[{"id":"https:\/\/ror.org\/00rbzpz17","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Model-informed precision dosing is increasingly integrated into therapeutic drug monitoring to optimize individualized pharmacotherapy, with maximum a posteriori Bayesian estimation serving as a key tool for pharmacokinetic parameter estimation. However, the impact of residual error specification on its precision remains underexplored. We hypothesized that reducing residual error would decrease the imprecision of area under the concentration\u2013time curve predictions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Using rich pharmacokinetics datasets comprising 321 profiles for tacrolimus, iohexol, and mycophenolate mofetil, maximum a posteriori Bayesian estimation was applied based on sparse sampling (3 time points) using published population pharmacokinetics models. Proportional residual error settings were varied as near-zero (10\n                      <jats:sup>\u22128<\/jats:sup>\n                      %), low (1%, \u201cFlat1\u201d), and the original published model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A low proportional error reduced the overall root mean square error of individual area under the concentration\u2013time curve predictions by 30%\u201340% compared with the original residual error configuration. For tacrolimus, the root mean square error decreased from 28.5% under the published error model to 16.3% with a 1% error setting, whereas for iohexol, a near-zero residual error achieved up to a 40% reduction. The near-zero error scenario yielded the most accurate area under the concentration\u2013time curve estimates for 45%\u201362% of patients across drug models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Reducing residual errors in maximum a posteriori Bayesian estimation significantly strengthens the influence of observed data on posterior calculations, improving the precision area under the concentration\u2013time curve and dosing accuracy without requiring additional data acquisition or model redevelopment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001413","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T14:00:08Z","timestamp":1765202408000},"page":"443-450","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Better Dosing Through Better Error: Residual Error as a Hidden Lever in Model-Informed Precision Dosing"],"prefix":"10.1097","volume":"48","author":[{"given":"Racym","family":"Berrah","sequence":"first","affiliation":[{"name":"Pharmacology & Transplantation, INSERM U1248, University of Limoges, Limoges, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Minichmayr","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1695-0695","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Woillard","sequence":"additional","affiliation":[{"name":"Pharmacology & Transplantation, INSERM U1248, University of Limoges, Limoges, France;"},{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the IATDMCT Pharmacometrics Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"R1-20261114","doi-asserted-by":"crossref","first-page":"115421","DOI":"10.1016\/j.addr.2024.115421","article-title":"Model-informed precision dosing: state of the art and future perspectives","volume":"215","author":"Minichmayr","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"R2-20261114","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/psp4.12684","article-title":"A hybrid machine learning\/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors","volume":"10","author":"Hughes","year":"2021","journal-title":"CPT Pharmacometric Syst Pharma"},{"key":"R3-20261114","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2125.2010.03837.x","article-title":"Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf","volume":"71","author":"Woillard","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"R4-20261114","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phrs.2017.12.005","article-title":"Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients","volume":"129","author":"Marquet","year":"2018","journal-title":"Pharmacol Res"},{"key":"R5-20261114","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/FPC.0b013e32801430f8","article-title":"Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients","volume":"17","author":"Djebli","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R6-20261114","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ekir.2019.11.012","article-title":"Measured GFR by utilizing population pharmacokinetic methods to determine iohexol clearance","volume":"5","author":"\u00c5sberg","year":"2020","journal-title":"Kidney Int Rep"},{"key":"R7-20261114","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.4254\/wjh.v14.i8.1621","article-title":"Iohexol plasma and urinary concentrations in cirrhotic patients: a pilot study","volume":"14","author":"Carrier","year":"2022","journal-title":"World J Hepatol"},{"key":"R8-20261114","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/jcph.1118","article-title":"Tacrolimus population pharmacokinetics and multiple CYP3A5 genotypes in black and white renal transplant recipients","volume":"58","author":"Campagne","year":"2018","journal-title":"J Clin Pharma"},{"key":"R9-20261114","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s40262-021-00998-z","article-title":"Model-based estimation of iohexol plasma clearance for pragmatic renal function determination in the renal transplantation setting","volume":"60","author":"Zwart","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"R10-20261114","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s40262-019-00771-3","article-title":"Population pharmacokinetics of mycophenolic acid co-administered with tacrolimus in corticosteroid-free adult kidney transplant patients","volume":"58","author":"Rong","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"R11-20261114","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/psp4.12467","article-title":"Quantitative systems pharmacology and physiologically-based pharmacokinetic modeling with mrgsolve: a hands-on tutorial","volume":"8","author":"Elmokadem","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"R12-20261114","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/psp4.12689","article-title":"Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayr","volume":"10","author":"Le Louedec","year":"2021","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"R13-20261114","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40262-018-0687-9","article-title":"Comment on \u201cPopulation pharmacokinetics of mycophenolic acid: an update\u201d","volume":"57","author":"Woillard","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"R14-20261114","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther Drug Monit"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:00:11Z","timestamp":1794664811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001413","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"2025-07-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}